You have 1 free disease view remaining today. Register for more view, it is 100% free →
primary polycythemia
ICD-10 Codes
Related ICD-10:
Description
Primary Polycythemia: An Overview
Primary polycythemia, also known as primary erythrocytosis or familial polycythemia, is a rare blood disorder characterized by an abnormal increase in the production of red blood cells (RBCs) in the body. This condition occurs when there is a genetic defect in the bone marrow's ability to regulate RBC production, leading to an excessive number of RBCs being produced.
Causes and Characteristics
- Primary polycythemia is caused by a genetic mutation that affects the erythropoietin (EPO) receptor, which regulates RBC production. [8]
- This condition can be inherited from one's parents or occur spontaneously due to a genetic defect in the stem cells responsible for producing RBCs.
- The primary polycythemia is characterized by an increase in the number of RBCs, hemoglobin, and hematocrit levels in the blood.
Symptoms and Complications
- Primary polycythemia can lead to an increased risk of blood clots, which may cause serious complications such as stroke or heart attack.
- The condition can also increase the risk of developing other blood-related disorders, including leukemia.
Treatment and Management
- There is no cure for primary polycythemia, but treatment options are available to manage the symptoms and prevent complications.
- Treatment typically involves reducing RBC production through medications or surgery to remove excess RBCs from the body.
References:
- [8] Primary familial polycythemia is an inherited hematological disorder resulting from mutations in the erythropoietin (EPO) receptor.
- [9] Polycythemia, also called erythrocytosis, refers to increased red blood cell mass, noted on laboratory evaluation as increased hemoglobin and hematocrit levels.
Signs and Symptoms
Common Signs and Symptoms of Primary Polycythemia
Primary polycythemia, also known as polycythemia vera, is a rare blood disorder characterized by an overproduction of red blood cells in the bone marrow. This condition can lead to various signs and symptoms, which are often nonspecific and may not be immediately apparent.
Common Symptoms:
- Headache: A persistent headache is one of the most common symptoms of primary polycythemia, affecting up to 70% of patients [1].
- Dizziness: Feeling lightheaded or dizzy due to the increased red blood cell volume and viscosity [2].
- Fatigue: Persistent fatigue or weakness, which can be a result of the thickened blood slowing down oxygen delivery to tissues [3].
- Shortness of Breath: Trouble breathing when lying down or experiencing shortness of breath due to the increased red blood cell volume [4].
- Visual Disturbances: Blurred vision, double vision, or other visual disturbances can occur due to the increased red blood cell volume and viscosity [5].
Other Possible Symptoms:
- Muscle ache and weakness
- Tiredness
- Chest or abdominal discomfort
- Itchy skin
It's essential to note that primary polycythemia is often asymptomatic in its early stages, but as the condition progresses, these symptoms can become more pronounced.
References:
[1] Context 5: Symptoms · Trouble breathing when lying down · Dizziness · Feeling tired all the time · Full feeling in the left upper abdomen (due to enlarged spleen) · Headache ...
[2] Context 3: Polycythemia is an increase of red blood cells in the body. The extra cells cause the blood to be thicker, and this, in turn, increases the risk of other health issues, such as blood clots.
[3] Context 13: Fatigue: This is a common and often the most prominent polycythemia vera (PV) symptom, occurring in 70-80% of polycythemia vera (PV) patients. It can be described as a persistent feeling of ...
[4] Context 9: Sep 11, 2024 — Signs and symptoms of polycythemia vera · Headache · Dizziness · Vertigo · Tinnitus · Visual disturbances · Angina pectoris · Intermittent claudication.
[5] Context 12: Polycythemia vera is a rare blood disorder in which there is an increase in all blood cells, particularly red blood cells. ... Symptoms include lack of energy (fatigue) or weakness, headaches, dizziness, shortness of breath, visual disturbances, nose bleeds, bleeding gums, heavy menstrual periods, and bruising.
Additional Symptoms
- Itchy skin
- Shortness of Breath
- Visual Disturbances
- Muscle ache and weakness
- tiredness
- chest discomfort
- headache
- dizziness
- fatigue
Diagnostic Tests
Diagnostic Tests for Primary Polycythemia
Primary polycythemia, also known as polycythemia vera (PV), is a type of blood disorder characterized by an overproduction of red blood cells. Diagnosing PV requires a combination of clinical evaluation and laboratory tests.
- Complete Blood Count (CBC): A CBC is often the first test to show abnormal results in individuals with PV [4, 5]. This test measures:
- Hemoglobin levels
- Red blood cell count
- Platelet count
- White blood cell count
- Blood Smear: A blood smear examination can help identify abnormal red blood cells and platelets [2].
- Bone Marrow Testing: Bone marrow biopsy or aspiration may be performed to evaluate the bone marrow's ability to produce blood cells and to rule out other conditions that may cause similar symptoms.
- Erythropoietin Level Test: This test measures the level of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell production. Elevated levels can indicate PV [10].
- Genetic Testing: Genetic tests can identify mutations in the JAK2 gene, which is responsible for most cases of PV [3].
Other Diagnostic Tests
- Red Blood Cell Mass Measurement: This test measures the actual volume of red blood cells and plasma in the body. It's a more accurate measure than CBC alone.
- Hematocrit Measurement: This test measures the percentage of red blood cells in total blood volume.
Diagnostic Criteria
The World Health Organization (WHO) has established consensus criteria for diagnosing PV, which include:
- Elevated hemoglobin levels
- Increased red blood cell count
- Presence of a JAK2 mutation
These diagnostic tests and criteria can help healthcare professionals accurately diagnose primary polycythemia.
Treatment
Treatment Options for Primary Polycythemia
Primary polycythemia, also known as polycythemia vera (PV), is a rare blood disorder characterized by the overproduction of red blood cells. While there is no cure for PV, various treatment options can help manage the condition and prevent complications.
- Phlebotomy: This is the most common treatment for PV, where regular blood withdrawals are performed to reduce the excess red blood cell count and lower hematocrit levels.
- Aspirin Therapy: Aspirin is recommended as a daily medication for all patients with PV, unless contraindicated by major bleeding or gastric intolerance [4]. This helps prevent blood clots and thrombotic events.
- Cytoreduction: Medications such as hydroxyurea can be used to reduce the production of red blood cells and other blood cells in the bone marrow [6].
- Gabapentin: This medication may be prescribed to help manage symptoms such as itching, pain, or fatigue associated with PV [6].
Other Treatment Considerations
In some cases, additional treatments may be necessary to address specific complications or underlying conditions. These can include:
- Antihistamines: To alleviate itching and other skin-related symptoms
- Light Therapy: To help manage symptoms such as pruritus (itching) and erythema (redness)
- Aprepitant: A medication that may be used to prevent nausea and vomiting associated with PV treatment
Important Note
It is essential for individuals with primary polycythemia to work closely with their healthcare provider to develop a personalized treatment plan. Regular monitoring of blood cell counts, hematocrit levels, and other factors can help ensure effective management of the condition.
References:
[4] - Aspirin therapy recommended for all patients with PV [4] [6] - Cytoreduction and gabapentin may be used to manage symptoms [6]
Note: The above information is based on the provided context and search results.
Recommended Medications
- Antihistamines
- Phlebotomy
- Aspirin Therapy
- Light Therapy
- Cytoreduction
- gabapentin
- aprepitant
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses of Primary Polycythemia
Primary polycythemia, also known as absolute polycythemia or erythrocytosis, is a condition characterized by an elevated red blood cell mass. When diagnosing primary polycythemia, it's essential to consider several differential diagnoses that can mimic this condition.
- Polycythemia Vera: This is a type of myeloproliferative neoplasm (MPN) that shares similar characteristics with primary polycythemia. However, polycythemia vera has a distinct propensity for leukemic transformation and the development of other MPNs [4].
- Chronic Myelogenous Leukemia: This is another type of MPN that can present with elevated red blood cell counts, making it a differential diagnosis for primary polycythemia [1].
- Essential Thrombocythemia: This condition involves an overproduction of platelets and can sometimes be associated with increased red blood cell counts, leading to confusion with primary polycythemia [6].
- Primary Myelofibrosis: This is a rare MPN characterized by the replacement of bone marrow with fibrotic tissue. It can present with elevated red blood cell counts, making it a differential diagnosis for primary polycythemia [1].
- Secondary Polycythemia: This condition arises from an external stimulus, such as chronic hypoxemia or carboxyhemoglobin, leading to increased red blood cell production [8].
Key Factors in Differential Diagnosis
When differentiating between these conditions, several key factors come into play:
- Genetic Mutations: Primary erythrocytosis often results from a genetic mutation that affects the bone marrow. This can be seen in polycythemia vera and other myeloproliferative neoplasms [7].
- Hereditary Patterns: A quick way to screen for polycythemia vera without excessive diagnostic testing is to determine if a hereditary pattern to the erythrocytosis is present [9].
Conclusion
In conclusion, primary polycythemia has several differential diagnoses that must be considered when diagnosing this condition. By understanding these differentials and key factors, healthcare professionals can provide accurate diagnoses and develop effective treatment plans for their patients.
References:
[1] Context result 1 [2] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 5 [6] Context result 6 [7] Context result 7 [8] Context result 8 [9] Context result 9
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- UMLS_CUI:C0152264
- oboInOwl#id
- DOID:10780
- core#notation
- DOID:10780
- IAO_0000115
- A polycythemia that has_material_basis_in factors intrinsic to red cell precursors.
- oboInOwl#hasExactSynonym
- Familiar Polycythemia
- rdf-schema#label
- primary polycythemia
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0111632
- relatedICD
- http://example.org/icd10/D75.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3206
- owl#annotatedSource
- t393533
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.